Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Krishna

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology in Drug Development|April 19, 2017
Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of RaltegravirRajesh Krishna, Matthew L Rizk, Patrick Larson, et al.
Clinical Pharmacology and Therapeutics|April 16, 2025
Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development PerspectiveRajesh Krishna, Satyendra Suryawanshi, Juliane Rascher, et al.
Cureus|June 21, 2024
Comparative Evaluation of Fracture Resistance of Carbon Fiber Posts and Glass Fiber Posts in Permanent Anterior Teeth: An In Vitro StudySaurabh Joshi, Pratima Shah, Dhananjay Gandhage, et al.
Molecular Biology Reports|May 22, 2026
ADAM9: an updated view of its biology and pathologyAkhila Sheela, Althaf Mahin, Suhail Subair, et al.
The AAPS Journal|February 25, 2011
Model-based development of anacetrapib, a novel cholesteryl ester transfer protein inhibitorRajesh Krishna, Arthur J Bergman, Michele Green, et al.
Nature Reviews. Drug Discovery|December 16, 2024
IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseasesRajesh Krishna, Anneliene H Jonker, Thomas Morel, et al.
The Journal of Pharmacy and Pharmacology|September 28, 2016
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravirRajesh Krishna, Lilly East, Patrick Larson, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
Journal of Clinical Pharmacology|July 21, 2018
Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy SubjectsRajesh Krishna, Ferdous Gheyas, Christy Corr, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|January 12, 2026
Somatosensory aura in hippocampal seizures captured during invasive EEG recording - A novel observationAmrutha Puthalath Chekkura, Sachin Sureshbabu, Tushar Vadakke Puthanveetil, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology in Drug Development|April 19, 2017
Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of RaltegravirRajesh Krishna, Matthew L Rizk, Patrick Larson, et al.
Clinical Pharmacology and Therapeutics|April 16, 2025
Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development PerspectiveRajesh Krishna, Satyendra Suryawanshi, Juliane Rascher, et al.
Cureus|June 21, 2024
Comparative Evaluation of Fracture Resistance of Carbon Fiber Posts and Glass Fiber Posts in Permanent Anterior Teeth: An In Vitro StudySaurabh Joshi, Pratima Shah, Dhananjay Gandhage, et al.
Molecular Biology Reports|May 22, 2026
ADAM9: an updated view of its biology and pathologyAkhila Sheela, Althaf Mahin, Suhail Subair, et al.
The AAPS Journal|February 25, 2011
Model-based development of anacetrapib, a novel cholesteryl ester transfer protein inhibitorRajesh Krishna, Arthur J Bergman, Michele Green, et al.
Nature Reviews. Drug Discovery|December 16, 2024
IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseasesRajesh Krishna, Anneliene H Jonker, Thomas Morel, et al.
The Journal of Pharmacy and Pharmacology|September 28, 2016
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravirRajesh Krishna, Lilly East, Patrick Larson, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
Journal of Clinical Pharmacology|July 21, 2018
Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy SubjectsRajesh Krishna, Ferdous Gheyas, Christy Corr, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|January 12, 2026
Somatosensory aura in hippocampal seizures captured during invasive EEG recording - A novel observationAmrutha Puthalath Chekkura, Sachin Sureshbabu, Tushar Vadakke Puthanveetil, et al.
Pageof 10